<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3705">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03058679</url>
  </required_header>
  <id_info>
    <org_study_id>825907</org_study_id>
    <nct_id>NCT03058679</nct_id>
  </id_info>
  <brief_title>Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease</brief_title>
  <acronym>DINE-CD</acronym>
  <official_title>Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Crohn's and Colitis Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This protocol is designed to compare the effectiveness of two dietary interventions for
      patients with Crohn's disease (CD): the Specific Carbohydrate Diet (SCD) and a Mediterranean
      style diet (MSD) that has been demonstrated to have numerous other health benefits. The two
      diets will be compared in terms of their ability to resolve both the symptoms and bowel
      inflammation that characterize this debilitating disease.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2017</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptomatic remission</measure>
    <time_frame>6 weeks</time_frame>
    <description>Assessed by Short Crohn's Disease Activity Index - diarrhea, abdominal pain and general well being</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in bowel inflammation</measure>
    <time_frame>6 weeks</time_frame>
    <description>Calprotectin &lt;250 mcg/gm and &gt;50% reduction from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical remission</measure>
    <time_frame>6 weeks</time_frame>
    <description>Assessed by the Harvey Bradshaw Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in systemic inflammation</measure>
    <time_frame>6 weeks</time_frame>
    <description>hsCRP &lt; 5mg/L &gt;50% reduction from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">194</enrollment>
  <condition>Crohn Disease</condition>
  <arm_group>
    <arm_group_label>Specific Carbohydrate Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mediterranean Style Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>food for the diet will be provided to the participants for 6 weeks</description>
    <arm_group_label>Specific Carbohydrate Diet</arm_group_label>
    <arm_group_label>Mediterranean Style Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥18

          2. Documented diagnosis of Crohn's disease

          3. sCDAI score &gt;175

          4. Active inflammation documented by a FCP concentration &gt;250mcg/g or C-reactive protein
             (CRP)&gt;7 mg/L measured at screening.

          5. Access to a computer with internet and the ability to complete daily online surveys

          6. Capable of providing consent to participate

          7. Able to receive weekly food shipments delivered every Friday for 6 weeks

        Exclusion Criteria:

          1. Pregnancy

          2. sCDAI &gt;400

          3. Hospitalized patients

          4. Anticipated need for surgery within 6 weeks of randomization

          5. Initiation of thiopurines, methotrexate, natalizumab or vedolizumab within 12 weeks
             prior to randomization

          6. Initiation of anti-TNF agents within 8 weeks prior to randomization

          7. Start or change corticosteroids within 1 week of screening or a dose &gt;20mg/day
             prednisone or equivalent*

          8. Known symptomatic intestinal stricture

          9. Presence of an ostomy

         10. Baseline stool frequency &gt;4 bowel movements/day when well

         11. BMI&lt;16

         12. BMI ≥40

         13. Celiac disease

         14. Documented C difficile colitis within four weeks of screening

         15. Diabetes Mellitus requiring medication

         16. Albumin&lt;2.0mg/dl, within 4 weeks of screening (if tested as part of routine clinical
             care)

         17. Known allergy to nuts

         18. Other conditions that would be a contraindication to any of the study diets or
             preclude the participant from completing the study.

               -  Patients may continue these medications at stable dose for the first six weeks
                  and budesonide may be used at any dose. After the 6th week in the study,
                  patients may taper their steroid dose. The study will provide a recommended
                  taper schedule.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James D Lewis, MD, MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erin D Gilroy, BS</last_name>
    <phone>215-746-4218</phone>
    <email>egilroy@mail.med.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lisa C Nessel, MSS, MLSP</last_name>
    <phone>215-573-6003</phone>
    <email>nessel@mail.med.upenn.edu</email>
  </overall_contact_backup>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 16, 2017</lastchanged_date>
  <firstreceived_date>February 16, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diet</keyword>
  <keyword>specific carbohydrate diet</keyword>
  <keyword>Mediterranean style diet</keyword>
  <keyword>randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
